EPCAM and breast carcinoma: A unique, nature-inspired, long-circulating nanoparticles containing chemotherapy and imaging agents was developed to target and treat EpCAM+ breast cancer with minimal uptake to non-targeted cells as well as to visualize tumor; hence, treatment progress could be monitored at the same time (Figure 1).